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Abstract 
Methylmercury (MeHg) exposure at high concentrations poses significant neurotoxic threat to humans 
worldwide. The present study investigated the mechanisms of glutathione-mediated attenuation of MeHg 
neurotoxicity in primary cortical culture. MeHg (5 μM) caused depletion of mono- and disulfide glutathione in 
neuronal, glial and mixed cultures. Supplementation with exogenous glutathione, specifically glutathione 
monoethyl ester (GSHME) protected against the MeHg induced neuronal death. MeHg caused increased reactive 
oxygen species (ROS) formation measured by dichlorodihydrofluorescein (DCF) fluorescence with an early 
increase at 30 min and a late increase at 6 h. This oxidative stress was prevented by the presence of either 
GSHME or the free radical scavenger, trolox. While trolox was capable of quenching the ROS, it showed no 
neuroprotection. Exposure to MeHg at subtoxic concentrations (3 μM) caused an increase in system 
xc− mediated 14C-cystine uptake that was blocked by the protein synthesis inhibitor, cycloheximide (CHX). 
Interestingly, blockade of the early ROS burst prevented the functional upregulation of system xc−. Inhibition of 
multidrug resistance protein-1 (MRP1) potentiated MeHg neurotoxicity and increased cellular MeHg. Taken 
together, these data suggest glutathione offers neuroprotection against MeHg toxicity in a manner dependent 
on MRP1-mediated efflux. 
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MeHg methylmercury 
MRP1 multi-drug resistance protein 1 
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ROS reactive oxygen species 
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1. Introduction 
Methylmercury (MeHg) is an ubiquitous neurotoxicant posing significant threat to humans when 
ingested at high concentrations. Exposure to MeHg has been implicated as a factor in the development 
of neurodegenerative diseases such as Alzheimer's Disease, Parkinson's Disease, and amyotrophic lateral 
sclerosis (ALS) (Hock et al., 1998, Monnet-Tschudi et al., 2006, Praline et al., 2007). Humans are primarily 
exposed to MeHg through consumption of contaminated fish and shellfish. MeHg is formed by 
bacterial methylation of inorganic mercury in aquatic sediments (Clarkson, 1997). MeHg then travels up the food 
chain and accumulates in fish and shellfish, and is subsequently consumed by humans (Mahaffey et al., 2004). 
There is clear evidence for neurological deficits following exposure to high levels of mercury. For example, a 
large release of mercury into Minamata Bay in Japan led to toxic levels of exposure and severe injury to the local 
population, including neurological dysfunctions (Harada, 1995, Tsuda et al., 2009). In a separate incident, 
methylmercury-contaminated seed grain was sent to a population in Iraq with its consumption leading to severe 
neurological injuries (Myers et al., 2000). Acute exposure to high levels of mercury is known to target cerebellar 
granular neurons(Fonnum and Lock, 2000), however, due to the location of damage in neurodegenerative 
diseases, there is also interest in the effects of mercury on cortical neurons. While humans are exposed to other 
forms of mercury, such as elemental mercury found in dental amalgam restorations, or ethylmercury found in 
the commercial preservative, thimerosal, MeHg is of specific concern because it is easily absorbed in the 
gastrointestinal tract, and readily traverses the blood–brain barrier (BBB) (Bridges and Zalups, 2005, Bridges and 
Zalups, 2010). 
Proposed mechanisms for MeHg neurotoxicity are primarily focused on four possibilities: disruption of 
intracellular calcium and zinc ion homeostasis, likely involving mitochondrial deficits (Atchison and Hare, 
1994, Kawanai et al., 2009), redox imbalance by increased production of reactive oxygen species and/or by 
decreasing endogenous cellular antioxidant defenses (Ali et al., 1992, Yee and Choi, 1996, Aschner, 2000, Franco 
et al., 2007, Amonpatumrat et al., 2008, Wang et al., 2009), direct interactions with free protein sulfhydryl 
groups (Rooney, 2007), and inhibition of selenoenzymes, especially those involved in redox signaling (Carvalho 
et al., 2008). The present study is aimed at determining the effects of MeHg on the glutathione (GSH) cycling 
system and oxidative stress. 
Astrocytes are thought to be responsible for de novo synthesis 
of glutathione from glutamate, glycineand the rate limiting substrate, cysteine, which is brought into the 
astrocytes primarily in its oxidized form, cystine (Kranich et al., 1998). Glutathione can be utilized by the cell to 
reduce reactive oxygen species, for example, superoxide produced as a byproduct of mitochondrial energy 
production rapidly reacts to form hydrogen peroxide which is then reduced by glutathione to form glutathione-
disulfide(GSSG) and water in a reaction catalyzed by glutathione peroxidase. Glutathione may also be utilized as 
a xenobiotic detoxicant as has been well characterized involving chemotherapeutics in cancertreatment (Salinas 
and Wong, 1999). That is, glutathione can be directly conjugated to exogenous substrates via a disulfide 
bond with the free sulfhydryl groups; these reactions are directed by a class of enzymes known as glutathione-S-
transferases (GSTs) (Dringen, 2000, Dringen and Hirrlinger, 2003). GSH, GSSG and the glutathione-conjugates are 
then exported from the cell in a glutathione-dependent manner via multi-drug resistance proteins (MRP), 
specifically MRP1 in the CNS (Hirrlinger and Dringen, 2005, Minich et al., 2006). These glutathione molecules can 
then be broken down in the extracellular space by glutathione reductase, amino-peptidase N, or gamma-
glutamyl transpeptidase. This metabolism produces the substrate cysteine, which can be taken up and utilized 
by neurons to produce their own glutathione. In this way, neurons are dependent on astrocytes to supply 
glutathione (Dringen et al., 1999). Since glutathione serves a dual role as both an antioxidant and detoxicant, 
and both of these roles may offer independent protective mechanisms against MeHg, the present study 
examines the impact of MeHg on these aspects of glutathione action. 
2. Materials and methods 
2.1. Materials 
Timed pregnant Swiss Webster mice were obtained from Charles River Laboratories (Wilmington, DE, 
USA). Serum was from Atlanta Biologicals (Atlanta, GA, USA). NADPH was from Applichem (Darmstadt, 
Germany). Radiolabeled 14C-cystine was purchased from PerkinElmer (Boston, MA, USA). S-(4)-
carboxyphenylglycine (CPG) and MK571 were obtained from Tocris Bioscience (Ellisville, MO, USA). DCF was 
from Molecular Probes (Eugene, OR, USA). All other chemicals were from Sigma (St. Louis, MO, USA). 
2.2. Cortical cell cultures 
Mixed cortical cell cultures containing glial and neuronal cells were prepared from fetal (15–16 day 
gestation) mice as previously described (Lobner, 2000). Dissociated cortical cells were plated on 24-well plates 
(2.0 cm2 surface area per well) coated with poly-d-lysine and laminin in Eagles’ Minimal Essential Medium 
(MEM, Earle's salts, supplied glutamine-free) supplemented with 5% (v/v) heat-inactivated horse serum, 5% 
(v/v) fetal bovine serum, 2 mM glutamine and d-glucose (total 21 mM). Neuronal cultures were prepared exactly 
as above with the addition of 10 μM cytosine aribinocide 48 h after plating to inhibit glial replication (Dugan et 
al., 1995, Rush et al., 2010). Cultures were plated at approximately 8 hemispheres per plate in a volume of 
500 μl per well. Glial cultures were prepared as described for mixed cultures from cortical tissue taken from 
post-natal day 1–3 mice and plated at approximately 3 hemispheres per plate (Choi et al., 1987, Schwartz and 
Wilson, 1992, Rush et al., 2009). Cultures were maintained in humidified 5% CO2 incubators at 37 °C. Mice were 
handled in accordance with a protocol approved by our institutional animal care committee and in compliance 
with the Public Health Service Policy on Humane Care and Use of Laboratory Animals. All experiments were 
performed in media identical to growth media except lacking serum (MS) at a volume of 400 μl per well. All 
experiments were performed on mixed cortical cultures, except where noted. 
2.3. Assay of neuronal death 
Cell death was assessed in cultures by the measurement of lactate dehydrogenase (LDH), released from 
damaged or destroyed cells, in the extracellular fluid 24 h after the beginning of the insult. Insults were 
performed by washing cultures into MS or MS containing the indicated chemicals and incubating overnight. 
Control LDH levels were subtracted from insult LDH values, and results normalized to 100% neuronal 
death caused by 500 μM NMDA. Control experiments have shown previously that the efflux of LDH occurring 
from either necrotic or apoptotic cells is proportional to the number of cells damaged or destroyed (Koh and 
Choi, 1987, Lobner, 2000). Trypan blue staining indicated that the cell death observed was neuron selective. 
Cell-free experiments were performed to exclude the possibility of direct inhibition of LDH by MeHg. That is, 
MeHg at concentrations up to 10 μM do not alter the quantification of an LDH standard. 
2.4. Glutathione assay 
Total cellular glutathione and media glutathione were assayed using a modified enzymatic 
method(Baker et al., 1990, Lobner et al., 2003). Cultures were washed into MS with or without MeHg (5 μM) and 
incubated for 6 h. Media samples of 25 μl were taken after the drug application period and assayed as aliquots 
of supernatant below. Cultures were washed with cold (4 °C) HEPES buffered salinesolution, dissolved in 200 μl 
of 1% sulfosalicylic acid, and centrifuged. A 25 μl aliquot of the supernatant was combined with 150 μl of 0.1 M 
phosphate/5 mM EDTA buffer, 10 μl of 20 mM dithiobis-2-nitrobenzoic acid, 100 μl of 5 mM nicotinamide 
adenine dinucleotide phosphate (NADPH), and 0.2 U of glutathione reductase. Total glutathione was determined 
by kinetic analysis of absorbancechanges at 402 nm for 1.5 min, with concentrations determined by comparison 
to a standard curve. GSSG was measured as above except samples were treated with 2-vinylpyridine 
and triethanolaminefor 1 h prior to beginning the reaction. Cell-free experiments were performed to exclude 
the possibility of assay inhibition by the experimental reagents used. Due to inter-plate culture variance in 
absolute glutathione measures data in Table 1 are reported as percent respective intra-plate control glutathione 
measures. Untreated control values across all culture types were typically in the following ranges (represented 
as mean nmol/well): 1.99–3.33 cellular GSH, 0.24–0.50 media GSH, 0.14–0.74 cellular GSSG, 0.060–0.16 media 
GSSG. 
 
Table 1. Effect of MeHg (5 μM) on glutathione levels in glial, neuronal and mixed cortical cultures after 6 h 
exposure. 
Culture type GSH  GSSG   
Cellular Media Cellular Media 
Mixed 83.4 ± 4.7 22.8 ± 1.0 60.7 ± 5.7 12.6 ± 2.4 
Glia 44.8 ± 5.2 62.3 ± 9.8 18.4 ± 2.9 29.3 ± 3.7 
Neurons 59.6 ± 6.5 36.9 ± 1.8 20.6 ± 6.2 N/D 
Results are expressed as % untreated control (mean ± SEM, n = 8–16). All values are significantly different from 
control. N/D = not detectable. 
 
2.5. Assay for oxidative stress 
Oxidative stress was measured with 5-(and -6)-2′7′-dichlorodihydrofluorescein diacetate (DCF-DA) using 
a fluorescent plate reader following a modification of a previous method (Wang and Joseph, 1999, Lobner et al., 
2007). 10 μM of the non-fluorescent, lipophilic compound DCF-DA is added to the cultures for 30 min where it is 
de-esterified and may be oxidized to fluorescent DCF (2′,7′-dichlorofluorescein). Fluorescence is read using a 
Fluoroskan Ascent plate reader (Thermo LabSystems) with excitation and emission filters set to 485 nm and 
538 nm, respectively. Background fluorescence (no DCF added) was subtracted and the results normalized to 
control conditions. 
2.6. 14C-cystine uptake 
Radiolabeled cystine uptake was performed as previously described with modifications (Liu et al., 2009). 
Cultures were exposed to MS containing the indicated drug treatments for 24 h, or for 1 h followed by 23 h in 
drug-free MS. 24 h after the start of the experiment, cultures were washed into HEPES buffered saline solution 
and immediately exposed to 14C-cystine (0.025 μCi/mL, 200 nM total cystine) for 20 min. Following 14C-cystine 
exposure, cultures were washed with ice cold HEPES buffered saline solution and dissolved in 250 μl 
warm sodium dodecyl sulfate (0.1%). An aliquot (200 μl) was removed and added to scintillation fluid for 
counting. Values were normalized to 14C-cystine uptake in untreated controls of the same experimental plate. 
2.7. Determination of MeHg content in cells by ICP-MS 
Following 6 h exposure to MS with or without the indicated treatments, cultures were washed 3× with 
cold MS and then dissolved in 100 μl 1% sulfosalicylic acid. Samples were combined with 900 μl 5% HNO3 
containing 500 ppb Au and digested at 70 °C for 2 h. Digestions were then centrifuged at 6000 × g for 5 min and 
the supernatants were diluted with an additional 1 mL of 5% HNO3. Mercurycontent was determined using a 
Micromass Platform ICP-MS controlled by MassLynx software (Waters Corporation, Milford, 
MA). Isotopes 198Hg, 199Hg, 200Hg, 201Hg, 202Hg, and 204Hg were recorded and total mercury was quantified by 
comparing sample responses to those produced by commercial standards treated identically to the samples. 
2.8. Statistical analysis 
Differences between test groups were examined for statistical significance by means of one-way ANOVA 
followed by the Student–Neuman Keuls post hoc analysis, with p < 0.05 being considered significant. 
3. Results 
Methylmercury (0.3–10 μM) exposure induced concentration-dependent neurotoxicity in mixed 
neuronal and glial cortical cultures 24 h after onset of insult (Fig. 1). Cell death was assayed by release of the 
cytosolic enzyme LDH 24 h after the beginning of the insult. Further, trypan blue staining of these cultures 
demonstrated that the MeHg-induced toxicity at the concentrations tested was purely neuronal (data not 
shown). From these data we chose 5 μM MeHg as a moderate insult for subsequent experiments as it allows 
bidirectional alterations to MeHg-induced neurotoxicity (i.e. neuroprotectionor potentiation). For other 
experiments we used 3 μM MeHg as a low-level insult as no significant neurotoxicity was observed at this 
concentration (Fig. 1). 
 
 
Fig. 1. Concentration response curve of MeHg (24 h exposure) on LDH release in primary cortical culture. Results 
are expressed as mean + SEM (n = 8–16). *Significant difference from untreated control. 
 
MeHg toxicity has been shown to cause glutathione depletion in several cell types (Kitahara et al., 
1993, Kaur et al., 2006, Amonpatumrat et al., 2008). We found that exposure of mixed neural and glial, pure 
neuronal and pure glial cultures to 5 μM MeHg significantly decreased total GSH and disulfide 
glutathione (GSSG) levels in the cells as well as in the extracellular media (Table 1). This glutathionedepletion 
occurred following a 6 h MeHg exposure, a time that precedes cell death as no LDH activity was detectable at 
this time (data not shown). We next tested whether glutathione supplementation or the addition of the free 
radical scavenger, trolox could protect the neurons. 24 h co-treatment of MeHg with glutathione 
monoethyl ester (GSHME) but not trolox, was neuroprotective (Fig. 2). Since glutathione supplementation was 
protective, and this effect could be due to its nature as an antioxidant or a xenobiotic detoxicant, we next 
assessed the abilities of GSHME and Trolox to block MeHg-induced oxidative stress. 
 
 
Fig. 2. MeHg-induced neuronal death is attenuated by glutathione monoethyl ester (GSHME, 100 μM) but 
not trolox (100 μM). Results are expressed as mean + SEM (n = 16–20). *Significantly different from MeHg-
alone. 
 
Mixed neuronal and glial cortical cultures exhibited a biphasic pattern of oxidative stress induced by 
exposure to 5 μM MeHg for 0, 30, 60, 180 or 360 min (Fig. 3) as measured by fluorescence of DCF. 
DCF fluorescence peaked at 30 min, returned to control levels at 3 h and increased once again by 6 h following 
onset of MeHg insult. Both 100 μM GSHME and 100 μM trolox were capable of preventing the MeHg-induced 
rise in DCF fluorescence indicative of their ability to block MeHg-induced oxidative stress. However, trolox was 
much more effective than GSHME actually decreasing the DCF signal well below control levels. 
 
 
Fig. 3. Timecourse of MeHg (5 μM) induced ROS formation as detected by DCF fluorescence. Results are 
expressed as mean + SEM (n = 8–16) after normalizing to average fluorescence of untreated controls (i.e. DCF 
only). *Significantly different from untreated controls. 
 
To further examine MeHg induced alterations to glutathione-related systems, we next tested whether 
low-level MeHg exposure had an effect on cellular uptake of cystine, the rate limiting substrate for GSH 
synthesis. Acute exposure to MeHg had no effect on 14C-cystine uptake (3 μM MeHg, 20 min exposure, data not 
shown); however, 24-h exposure to low-level MeHg (3 μM) caused a robust increase in subsequent 14C-cystine 
uptake that was blocked by co-treatment with the protein synthesisinhibitor, cycloheximide (CHX, 500 ng/mL) 
(Fig. 4A). To determine whether the MeHg-induced increase in cystine uptake was mediated by 
cystine/glutamate exchange, we tested the effects of an inhibitor of this system, CPG (300 μM, present only 
during the 20 min uptake period). The finding that CPG blocked the MeHg-induced increase in cystine uptake 
indicates that the increase was entirely mediated by functional upregulation of system xc−. When attempting to 
determine the effect of trolox on the MeHg-induced increase, we found that overnight exposure to trolox alone 
induced a large increase in subsequent cystine uptake (data not shown). To avoid this complication we used an 
altered protocol shortening the exposure time to the trolox and/or MeHg to 1 h, followed by a 23 h incubationin 
identical exposure media except lacking the trolox and MeHg. 60 min exposure to MeHg (3 μM) produced a 
similar increase in xCT-mediated cystine uptake 23 h later (Fig. 4B). Co-treatment with trolox during this period 
blocked this increase while trolox alone for 60 min had no effect on uptake. 
 
 
Fig. 4. Subtoxic MeHg exposure causes a robust increase in system xc− mediated 14C-cystine uptake. (A) Cultures 
were exposed to MeHg (3 μM), cycloheximide (CHX, 500 ng/mL), or in combination for 24 h prior to measuring 
uptake. Carboxyphenylglycine (CPG, 300 μM) was present only during the 20 min uptake period. (B) Cultures 
were exposed to MeHg (3 μM), trolox (100 μM) or in combination for 60 min, washed into drug-free media and 
incubated overnight (23 h) prior to assay for cystine uptake. Results are expressed as mean + SEM (n = 8–16) 
after normalizing to untreated control uptake. *Significantly different from control. 
 
It is possible that glutathione conjugates to MeHg intracellularly and that this conjugate is exported 
via MRP1. To test whether the export of glutathione is necessary for its protective capabilities, we co-treated 
cultures with MeHg and an inhibitor of MRP1, MK571. MK571 alone caused no significant cell toxicity; however, 
by inhibiting MRP1-mediated glutathione export MeHg neurotoxicity was severely potentiated (Fig. 5A). 
Supporting the idea that MeHg conjugates to GSH, we found that inhibiting MRP1-mediated glutathione export 
with MK571 led to a doubling of MeHg accumulation within the cellular compartment (Fig. 5B). 
Supplementation with GSHME during the MeHg treatment had no effect on mercury accumulation in the cells 
(data not shown). 
 
Fig. 5. Blockade of glutathione efflux augments MeHg toxicity and cellular accumulation of mercury. (A) Cultures 
were exposed to MeHg (5 μM), MK571 (10 μM), or both in combination with or without GSHME (100 μM) for 
24 h at which time samples were taken and neuronal death quantified by LDH release. Results are expressed as 
mean + SEM (n = 8–12). *Significantly different from untreated control, #significantly different from MeHg-only 
treated. (B) Cultures were exposed to MeHg (5 μM) in the presence of GSHME (100 μM) or MK571 (50 μM) for 
6 h. Samples were then taken and subsequently analyzed for mercury content by ICP-MS. Results are expressed 
as mean + SEM (n = 3–6). 
4. Discussion 
The present study offers several insights into the contributions of alterations in glutathione cycling 
and oxidative stress to methylmercury-induced neurotoxicity. We observed significant toxicity with overnight 
exposure of mixed cortical cultures to 5 μM MeHg. This concentration is similar to those used in other studies 
demonstrating cytotoxicity, oxidative stress and mitochondrial deficits in cortical and cerebellar 
granular neuron (CGN) cultures (Gasso et al., 2001, Morken et al., 2005, Kaur et al., 2006, Yin et al., 2007). 
However, it is important to note that CGNs have been shown to be more sensitive to MeHg toxicity (Sarafian 
and Verity, 1991, Marty and Atchison, 1997, Sakaue et al., 2005). Though not the only factor recognized, the 
increased sensitivity of CGNs has been posited as attributable to the relatively low glutathione content of these 
cells (Yee and Choi, 1996, Shafer et al., 2002, Kaur et al., 2007, Wang et al., 2009). 
Previous studies have shown that MeHg causes a depletion of cellular glutathione (Yee and Choi, 
1996, Franco et al., 2007, Amonpatumrat et al., 2008, Wang et al., 2009). Here, we also report that MeHg 
depletes both total and disulfide glutathione in cortical culture; total GSH and disulfide GSSG were decreased in 
cellular and media samples from glia-enriched, neuron-enriched and mixed cultures. GSH can reduce free 
radicals or eliminate exogenous molecules from the cell. The MeHg-induced loss of glutathione may be due to 
the formation of ROS and subsequent use of GSH by the cells to reduce the oxidative damage. However, since 
reduction of oxidative stress by GSH results in the formation of GSSG, the observed depletion of both GSH and 
GSSG suggests that the loss of glutathione was not due to oxidative stress. This data is consistent with 
the hypothesis that glutathione is acting to detoxify MeHg by direct conjugation which may render the utilized 
GSH molecules undetectable by our assay, and perhaps unrecoverable by the cell. 
It has been shown that modulation of cellular thiols (including GSH) alters sensitivity to MeHg in culture 
(Kaur et al., 2006) and that exogenous supply of glutathione precursors such as N-acetyl-cysteine (NAC) 
or cystine is neuroprotective (Fujiyama et al., 1994, Kaur et al., 2006, Kaur et al., 2007). Specifically, NAC is able 
to boost cellular GSH availability and leads to decreased MeHg-induced cytotoxicity and ROS formation. 
Inhibition of glutathione synthesis with buthionine sulfoxamine (BSO) increases sensitivity to MeHg and 
increases subsequent ROS formation (Toyama et al., 2011). These studies also demonstrate that modulation of 
glutathione availability alters cellular ROS formation in response to MeHg insult. Further, this ROS formation is 
sensitive to antioxidants (Gasso et al., 2001, Shanker and Aschner, 2003, Kaur et al., 2010). Importantly, 
however, in our hands troloxdoes not offer the neuroprotective capacity that glutathione supplementation with 
GSHME provides. This suggests that oxidative stress alone is not primary to the toxicity of MeHg under these 
conditions. Others have shown that trolox does offer neuroprotection against early MeHg-induced 
mitochondrial deficits detected by MTT metabolism after short, 1 h exposure (Kaur et al., 2010). Notably, 
however, these studies did not investigate later timepoints as seen in the present data. 
An important action of MeHg is the inhibition of selenoproteins. Among the selenoproteins that MeHg 
has been shown to inhibit are thioredoxin reductase and thioredoxin-glutathione peroxidase(Carvalho et al., 
2008, Reeves and Hoffmann, 2009, Branco et al., 2011). In fact, the IC50 for the inhibition of thioredoxin 
reductase 1 is 9 nM (Carvalho et al., 2008); therefore, at the concentrations of MeHg used in the current study 
this enzyme, and similar selenoproteins, are likely greatly inhibited. Therefore, it is clear that interaction with 
selenoproteins could be a mechanism of MeHg induced GSH depletion and oxidative stress. However, while 
preincubation with selenomethionine has been shown to attenuate MeHg induced production of reactive 
oxygen species, it did not prevent depletion of GSH (Kaur et al., 2009). Although, dietary selenium is known to 
be protective against MeHg exposure (Ralston and Raymond, 2010). 
MeHg can also inhibit other enzymes important for the cells response to oxidative stress, such as 
thioredoxin and glutathione reductase (Carvalho et al., 2008). However, the inhibition of glutathione 
reductase was found to only occur in vitro and not in cells treated with MeHg (Carvalho et al., 2008). 
We also examined the function of the cystine–glutamate antiporter in response to MeHg exposure by 
radiolabeled 14C-cystine uptake. As discussed above, cystine uptake is an important aspect of glutathione 
synthesis and subsequent cycling. Low-level MeHg insult induced a robust increase in cystine uptake. 
This functional upregulation of xCT was blocked by CHX suggesting that the upregulation requires translation of 
new protein. As well, CPG blocked this increased radioliganduptake to CPG-treated control levels suggesting the 
entire MeHg-induced increase was mediated by system xc−. Trolox also blocked the MeHg-increased cystine 
uptake. Considering that upregulation of xCT is likely an endogenous mechanism of cytoprotection in response 
to MeHg-insult, the fact that trolox blocks upregulation of xCT may account for the inability of trolox to protect 
against the neuronal injury. The most likely mechanism for increased system xc− activity is upregulation of xCT 
by activation of the nrf2-ARE pathway (Mysona et al., 2009, Wang et al., 2009, Qin et al., 2010). Consistent with 
this explanation is a recent report demonstrating nrf2-dependent methylmercury detoxificationin hepatocytes 
(Toyama et al., 2011) and an earlier report in astrocytes (Wang et al., 2009). 
The current data indicate that blockade of oxidative stress alone is insufficient to prevent MeHg-
induced neuronal death, and that elimination of MeHg from the cell by conjugation to GSH is necessary. 
Consistent with this, inhibition of glutathione export via the MRP1 inhibitor, MK571, not only potentiated MeHg-
induced neurotoxicity, but this potentiation was associated with increased accumulation of MeHg in the cell. 
Similar results have been reported in primary mouse hepatocytes where it was found that upregulation 
of MRP1 by isothiocyanates decreased MeHg accumulation and toxicity (Toyama et al., 2011). Interestingly, and 
consistent with a previous report using NAC (Kaur et al., 2006), glutathione supplementation with GSHME did 
not affect MeHg accumulation in the cell. Trolox has previously been reported to have no effect on MeHg 
accumulation nor on glutathione availability (Kaur et al., 2010); these and the present data, support the 
assertion that oxidative stress is not primary to MeHg-induced neurotoxicity. Rather, conjugation with MeHg 
and subsequent export of glutathione from the cytosol is crucial to alleviate or prevent MeHg-induced 
neurotoxicity and that solely blocking oxidative stress is not likely to offer significant neuroprotection. 
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